Literature DB >> 24931719

STAT transcription factors in normal and cancer stem cells.

Kathleen A Dorritie1, Robert L Redner2, Daniel E Johnson3.   

Abstract

Signal transducer and activator of transcription proteins (STATs) play vital roles in the regulation of cellular proliferation and survival in normal hematopoietic cells, including hematopoietic stem cells. However, aberrant activation of STATs is commonly observed in a number of hematologic malignancies, and recent studies indicate that targeting of STATs may have therapeutic benefit in these diseases. Additional studies have provided greater understanding of the cells responsible for leukemia initiation, referred to as leukemia stem cells. Emerging evidence indicates that STATs are important in maintaining leukemia stem cells and represent a promising target for eradication of this dangerous cell population. Here we summarize what is known about normal hematopoietic stem cells and the origin of leukemic stem cells. We further describe the roles of STAT proteins in these cell populations, as well as current progress toward the development of novel agents and strategies for targeting the STAT proteins.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; JAK; Leukemia; STAT

Mesh:

Substances:

Year:  2014        PMID: 24931719     DOI: 10.1016/j.jbior.2014.05.004

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  10 in total

1.  Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.

Authors:  Romain Duval; Linh-Chi Bui; Cécile Mathieu; Qing Nian; Jérémy Berthelet; Ximing Xu; Iman Haddad; Joelle Vinh; Jean-Marie Dupret; Florent Busi; Fabien Guidez; Christine Chomienne; Fernando Rodrigues-Lima
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

2.  Response of the JAK-STAT pathway to mammalian hibernation in 13-lined ground squirrel striated muscle.

Authors:  Samantha M Logan; Shannon N Tessier; Joann Tye; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2016-02-17       Impact factor: 3.396

Review 3.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 4.  The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.

Authors:  Jessica Kopenhaver; Madison Crutcher; Scott A Waldman; Adam E Snook
Journal:  Expert Opin Biol Ther       Date:  2021-05-24       Impact factor: 5.589

Review 5.  Leptin-Induced JAK/STAT Signaling and Cancer Growth.

Authors:  McKay Mullen; Ruben Rene Gonzalez-Perez
Journal:  Vaccines (Basel)       Date:  2016-07-26

Review 6.  Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.

Authors:  Komal Qureshi-Baig; Pit Ullmann; Serge Haan; Elisabeth Letellier
Journal:  Mol Cancer       Date:  2017-02-16       Impact factor: 27.401

7.  JAK/STAT guarantees robust neural stem cell differentiation by shutting off biological noise.

Authors:  Yoshitaro Tanaka; Tetsuo Yasugi; Masaharu Nagayama; Makoto Sato; Shin-Ichiro Ei
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

8.  Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma.

Authors:  Wei Ji; Yuankun Liu; Bin Xu; Jie Mei; Chao Cheng; Yong Xiao; Kun Yang; Weiyi Huang; Jiantong Jiao; Hongyi Liu; Junfei Shao
Journal:  Front Genet       Date:  2021-07-02       Impact factor: 4.599

9.  Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.

Authors:  Jei Ha Lee; Soo Im Choi; Rae Kwon Kim; Eun Wie Cho; In Gyu Kim
Journal:  Sci Rep       Date:  2018-07-16       Impact factor: 4.379

Review 10.  Cancer stem cells in progression of colorectal cancer.

Authors:  Yujuan Zhou; Longzheng Xia; Heran Wang; Linda Oyang; Min Su; Qiang Liu; Jingguan Lin; Shiming Tan; Yutong Tian; Qianjin Liao; Deliang Cao
Journal:  Oncotarget       Date:  2017-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.